SuicideNCT06810713
Evaluation of a Training for Healthcare Providers in Supporting Men Experiencing Suicidal Ideation
A study testing Gatekeeper training (e-learning) in people with Suicide and Suicidal Ideation, run by University Ghent at 1 site in Belgium.
Trial summary
The primary objective of this study is to assess how healthcare providers perceive and evaluate the developed e-learning. The findings will inform potential adjustments to enhance the e-learning as needed. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Suicide, Suicidal Ideation
- What is being tested?
- Gatekeeper training (e-learning)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 119 participants
- Where
- 1 siteBelgium
- Study dates
- 27 May 2025to 13 Jul 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthcare providers (e.g. GP's, psychiatrists, medical doctors, psychologists, psychotherapists, and nurses working in healthcare)
- ≥18y/o
- Access to a smartphone, tablet, or computer with internet connection and proficiency in Dutch
Who cannot join
- Does not meet the specified inclusion criteria.
Trial locations and contacts
1 site in 1 country.
Belgium1 site
Flemish Centre of Expertise in Suicide Prevention, Ghent University
Ghent, 9000
About this study
The primary objective of this study is to assess how healthcare providers perceive and evaluate the developed e-learning. The findings will inform potential adjustments to enhance the e-learning as needed.
Read the detailed description
In a previous study (BUN: B6702024000090), the authors focused on identifying barriers and needs among adult men experiencing suicidal thoughts and their healthcare providers. Findings from this needs assessment indicate a demand for a training (e-learning) to equip healthcare providers with strategies for working effectively with men experiencing suicidal ideation. Additionally, the assessment among individuals with suicidal ideation identified several key recommendations and considerations which healthcare providers should incorporate into their practice. Therefore, an e-learning was developed with integrated psycho-education and the primary objective of this study is to assess how healthcare providers perceive and evaluate the developed e-learning. The findings will inform potential adjustments to enhance the e-learning as needed.
Participants will be recruited through announcements on the Flemish suicide prevention portal website (www.zelfmoord1813.be) and websites of relevant partners (i.e. VVKP, VVP, Gezond Leven, Psyché, Vivel, Logo's, CGG-SP, Domus Medica,…), as well as via social media (mainly Linkedin, Instagram and Facebook) and newsletters of the Flemish Centre of Expertise in Suicide Prevention and its relevant partner organizations.
Individuals interested in participating will be directed to register online through REDCap, where they will review and approve an informed consent form.After providing informed consent, participants will be asked to provide their email address.
The email address will be used solely for the following purposes:
- Sending a reminder to complete the post-test questionnaire three days later. Once consent is provided, participants will be directed to the online pre-test questionnaire (see Table 1), which takes approximately 10 minutes to complete. Following the pre-test, participants will be directed to the e-learning module, which requires 30-60 minutes. At the end of the e-learning, healthcare providers will be asked to complete the post-test questionnaire, which is estimated to take 15 minutes. In case a participant does not complete the post-test, a reminder will be sent via e-mail three days later.
- Conditions
- Suicide, Suicidal Ideation
- Being tested
- Gatekeeper training (e-learning)
- Medical subject headings
- Suicide, Suicidal Ideation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Gatekeeper training (e-learning)Behavioural
This training supplements existing modules for healthcare providers working with individuals experiencing suicidal thoughts (https://sp-reflex.zelfmoord1813.be/e-learning).
Specific information on working with men will be added:
- Information on suicidality among men and the importance of gender-sensitive care.
- Guidance on recognizing signs of suicidality in men and understanding gender differences in suicide-related communication.
- Insights into the impact of gender norms and socialization on suicidality and help-seeking behavior in men experiencing suicidal thoughts.
- Awareness of providers' own gender biases and the influence of societal gender norms in treating men with suicidal ideation.
- Recommendations for engaging men in treatment, with specific guidance on language and approaches for interacting with men who have suicidal thoughts.
Additionally, the e-learning will a model psychoeducation about the role of norms for men experiencing suicidal ideation.
| Study group | Role | What they receive |
|---|---|---|
| Gatekeeper training (e-learning) | Experimental | Participants in this group (all participants) are asked to complete a questionnaire and then receive access to the online training (e-learning), after which they were asked to complete another questionnaire. In case a participant does not complete the post-test, a reminder will be sent via e-mail three days later. Receives: Behavioral: Gatekeeper training (e-learning) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Competencies related to working with male clients (self-efficacy)
Adaptation of the Engaging Men in Therapy Scale (EMITS): scale of 13 items to be rated on a scale from 1 (strongly disagree) to 5 (strongly agree), resulting in a total score of 13-65. Higher scores indicating higher self-reported competency for engaging with male clients.
The adapted version consists of 8 items, as not all aspects of the original questionnaire are included in the evaluated e-learning.
Measured: Change from Baseline (before e-learning) to post-test (immediatly after e-learning of 30-60 minutes); assessed up to 3 days after pre-test
Evaluation of the training
self-developed questionnaire: score on a scale of 1 (not good at all) to 10 (Excellent); 10 evaluation statements to be rated on a scale of 1 (totally disagree) to 5 (totally agree); 9 open questions; one question about the length of the e-learning (too short, too long or just fine)
Measured: Post-test (immediatly after e-learning of 30-60 minutes), up to 3 days after pre-test
Secondary outcomes (1)
self-efficacy
self-efficacy in working with men experiencing suicidal ideation: 2 questions on self-rated competence in recognizing and inquiring about suicide (1), discussing suicidal ideation withmen (2)to be rated on a 5-point scale (Not competent at all to very competent).
Measured: Change from Baseline (before e-learning) to post-test (immediatly after e-learning of 30-60 minutes); assessed up to 3 days after pre-test
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Feb 2025
- Study start27 May 2025
- Primary completion13 Jul 2025
- Study completion13 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for SuicideStudies of the same condition, open and under way.
- More trials run by University GhentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 119 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Ghent
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Gwendolyn Portzky, PhD, Principal investigator, University Ghent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06810713
- Sponsor's protocol ID
- ONZ-2024-0536
- Status last verified
- Apr 2026
- First submitted
- 22 Jan 2025
- Last updated
- 13 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Seidler ZE, Wilson MJ, Benakovic R, Mackinnon A, Oliffe JL, Ogrodniczuk JS, Kealy D, Owen J, Pirkis J, Mihalopoulos C, Le LK, Rice SM. A randomized wait-list controlled trial of Men in Mind: Enhancing mental health practitioners' self-rated clinical competencies to work with men. Am Psychol. 2024 Apr;79(3):423-436. doi: 10.1037/amp0001242. Epub 2023 Nov 27.
PubMed 38010768
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of a Training for Healthcare Providers in Supporting Men Experiencing Suicidal Ideation
- ClinicalTrials.gov ID
- NCT06810713
- Acronym / sponsor ID
- ONZ-2024-0536
- Conditions
- Suicide, Suicidal Ideation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 119 participants (actual)
- Lead sponsor
- University GhentUniversity, hospital or other
- Study start
- 27 May 2025 (actual)
- Primary completion
- 13 Jul 2025 (actual)
- Study completion
- 13 Jul 2025 (actual)
- First posted
- 5 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this study is to assess how healthcare providers perceive and evaluate the developed e-learning. The findings will inform potential adjustments to enhance the e-learning as needed.
Detailed description
In a previous study (BUN: B6702024000090), the authors focused on identifying barriers and needs among adult men experiencing suicidal thoughts and their healthcare providers. Findings from this needs assessment indicate a demand for a training (e-learning) to equip healthcare providers with strategies for working effectively with men experiencing suicidal ideation. Additionally, the assessment among individuals with suicidal ideation identified several key recommendations and considerations which healthcare providers should incorporate into their practice. Therefore, an e-learning was developed with integrated psycho-education and the primary objective of this study is to assess how healthcare providers perceive and evaluate the developed e-learning. The findings will inform potential adjustments to enhance the e-learning as needed.
Participants will be recruited through announcements on the Flemish suicide prevention portal website (www.zelfmoord1813.be) and websites of relevant partners (i.e. VVKP, VVP, Gezond Leven, Psyché, Vivel, Logo's, CGG-SP, Domus Medica,…), as well as via social media (mainly Linkedin, Instagram and Facebook) and newsletters of the Flemish Centre of Expertise in Suicide Prevention and its relevant partner organizations.
Individuals interested in participating will be directed to register online through REDCap, where they will review and approve an informed consent form.After providing informed consent, participants will be asked to provide their email address.
The email address will be used solely for the following purposes:
- Sending a reminder to complete the post-test questionnaire three days later. Once consent is provided, participants will be directed to the online pre-test questionnaire (see Table 1), which takes approximately 10 minutes to complete. Following the pre-test, participants will be directed to the e-learning module, which requires 30-60 minutes. At the end of the e-learning, healthcare providers will be asked to complete the post-test questionnaire, which is estimated to take 15 minutes. In case a participant does not complete the post-test, a reminder will be sent via e-mail three days later.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Gatekeeper training (e-learning) | Experimental | Behavioral: Gatekeeper training (e-learning)Participants in this group (all participants) are asked to complete a questionnaire and then receive access to the online training (e-learning), after which they were asked to complete another questionnaire. In case a participant does not complete the post-test, a reminder will be sent via e-mail three days later. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Healthcare providers (e.g. GP's, psychiatrists, medical doctors, psychologists, psychotherapists, and nurses working in healthcare)
- ≥18y/o
- Access to a smartphone, tablet, or computer with internet connection and proficiency in Dutch
Key exclusion criteria (1 listed)
- Does not meet the specified inclusion criteria.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Gatekeeper training (e-learning)This training supplements existing modules for healthcare providers working with individuals experiencing suicidal thoughts (https://sp-reflex.zelfmoord1813.be/e-learning). Specific information on working with men will be added: * Information on suicidality among men and the importance of gender-sensitive care. * Guidance on recognizing signs of suicidality in men and understanding gender differences in suicide-related communication. * Insights into the impact of gender norms and socialization on suicidality and help-seeking behavior in men experiencing suicidal thoughts. * Awareness of providers' own gender biases and the influence of societal gender norms in treating men with suicidal ideation. * Recommendations for engaging men in treatment, with specific guidance on language and approaches for interacting with men who have suicidal thoughts. Additionally, the e-learning will a model psychoeducation about the role of norms for men experiencing suicidal ideation. | Behavioural | Gatekeeper training (e-learning) |
Primary outcome
Competencies related to working with male clients (self-efficacy)
Time frame: Change from Baseline (before e-learning) to post-test (immediatly after e-learning of 30-60 minutes); assessed up to 3 days after pre-test
Adaptation of the Engaging Men in Therapy Scale (EMITS): scale of 13 items to be rated on a scale from 1 (strongly disagree) to 5 (strongly agree), resulting in a total score of 13-65. Higher scores indicating higher self-reported competency for engaging with male clients. The adapted version consists of 8 items, as not all aspects of the original questionnaire are included in the evaluated e-learning.
Evaluation of the training
Time frame: Post-test (immediatly after e-learning of 30-60 minutes), up to 3 days after pre-test
self-developed questionnaire: score on a scale of 1 (not good at all) to 10 (Excellent); 10 evaluation statements to be rated on a scale of 1 (totally disagree) to 5 (totally agree); 9 open questions; one question about the length of the e-learning (too short, too long or just fine)
1 secondary outcome
self-efficacy
Time frame: Change from Baseline (before e-learning) to post-test (immediatly after e-learning of 30-60 minutes); assessed up to 3 days after pre-test
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2026.
- Background: PubMed 38010768Seidler ZE, Wilson MJ, Benakovic R, Mackinnon A, Oliffe JL, Ogrodniczuk JS, Kealy D, Owen J, Pirkis J, Mihalopoulos C, Le LK, Rice SM. A randomized wait-list controlled trial of Men in Mind: Enhancing mental health practitioners' self-rated clinical competencies to work with men. Am Psychol. 2024 Apr;79(3):423-436. doi: 10.1037/amp0001242. Epub 2023 Nov 27.
- Individual participant dataSharing planned: No
Related trials for Suicide
Not yet recruiting
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Suicidal Ideas, Suicidal Ideation
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
SERENE Low-Intensity Focused Ultrasound for Cognitive Control
Suicidal Ideation, Cognitive Control
Not yet recruiting
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Alcohol Use Disorder (AUD), Suicide Ideation
Enrolling by invitation
Pilot Study of a Modified Safety Planning Intervention for Elementary School-Aged Children - Main Study
Suicidal Ideation, Suicidal Behaviors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gwendolyn Portzky, PhD principal investigator
University Ghent
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Gatekeeper training (e-learning) in people with Suicide and Suicidal Ideation, run by University Ghent at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Competencies related to working with male clients (self-efficacy) (time frame: Change from Baseline (before e-learning) to post-test (immediatly after e-learning of 30-60 minutes); assessed up to 3 days after pre-test). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06810713, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.